tradingkey.logo
搜索

Azenta Inc

AZTA
添加自选
25.941USD
-0.249-0.95%
交易中 美东报价延迟15分钟
1.20B总市值
亏损市盈率 TTM

Azenta Inc

25.941
-0.249-0.95%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.15%

5天

+8.51%

1月

+11.64%

6月

-22.16%

今年开始到现在

-22.16%

1年

-18.48%

关键数据
26.290今开
26.800最高
135.22K成交量
亏损市盈率 TTM
42.14市盈率动
--股息TTM
0.29%换手率
26.190昨收
25.700最低
2.47M成交额
亏损市盈率静
0.77市净率
0.00%股息率 TTM
-5.62%ROA
41.73052周最高
0.34量比
-55.76M净利润
46.09M总股本
-3.7659每股收益TTM
1.40Beta
-6.81%ROE
15.93052周最低
4.20%振幅
-119.86%毛利率
1.20B总市值
3.95回报/风险
2.98%风险率

TradingKey Azenta Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Azenta Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名25/387位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价28.50。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Azenta Inc评分

相关信息

行业排名
25 / 387
全市场排名
94 / 4564
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Azenta Inc亮点

亮点风险
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
利润高增长
公司净利润处于行业前列,最新年度总收入593.82M美元
估值高估
公司最新PE估值-6.95,处于3年历史高位
机构减仓
最新机构持股52.28M股,环比减少8.52%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值518.28K
活跃度降低
近期活跃度降低,过去20天平均换手率0.13

分析师目标

根据 7 位分析师
买入
评级
28.500
目标均价
+11.68%
涨幅空间

Azenta Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Azenta Inc简介

Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
公司代码AZTA
公司Azenta Inc
CEOMarotta (John)
网址https://www.azenta.com/

常见问题

Azenta Inc(AZTA)的当前股价是多少?

Azenta Inc(AZTA)的当前股价是 26.19。

Azenta Inc的股票代码是什么?

Azenta Inc的股票代码是AZTA。

Azenta Inc股票的52周最高点是多少?

Azenta Inc股票的52周最高点是41.73。

Azenta Inc股票的52周最低点是多少?

Azenta Inc股票的52周最低点是15.93。

Azenta Inc的市值是多少?

Azenta Inc的市值是1.21B。

现在Azenta Inc(AZTA)的股票是买入、持有还是卖出?

根据分析师评级,Azenta Inc(AZTA)的总体评级为买入,目标价格为28.50。

Azenta Inc(AZTA)股票的每股收益(EPS TTM)是多少

Azenta Inc(AZTA)股票的每股收益(EPS TTM)是-1.22。